This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Acuvi Balance Sheet Health

Financial Health criteria checks 5/6

Acuvi has a total shareholder equity of SEK281.8M and total debt of SEK56.5M, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are SEK404.7M and SEK123.0M respectively. Acuvi's EBIT is SEK29.3M making its interest coverage ratio 58.4. It has cash and short-term investments of SEK15.3M.

Key information

20.0%

Debt to equity ratio

SEK 56.49m

Debt

Interest coverage ratio58.4x
CashSEK 15.30m
EquitySEK 281.77m
Total liabilitiesSEK 122.97m
Total assetsSEK 404.75m

Recent financial health updates

No updates

Recent updates

No updates

Financial Position Analysis

Short Term Liabilities: ACUVI BTA's short term assets (SEK100.9M) exceed its short term liabilities (SEK64.4M).

Long Term Liabilities: ACUVI BTA's short term assets (SEK100.9M) exceed its long term liabilities (SEK58.6M).


Debt to Equity History and Analysis

Debt Level: ACUVI BTA's net debt to equity ratio (14.6%) is considered satisfactory.

Reducing Debt: ACUVI BTA's debt to equity ratio has increased from 6.1% to 20% over the past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: Whilst unprofitable ACUVI BTA has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.

Forecast Cash Runway: ACUVI BTA is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 10.2% per year.


Discover healthy companies